COMMUNIQUÉS West-GlobeNewswire

Tabula Rasa HealthCare Acquires Cognify an Integration HealthCare Technology Company
08/11/2018
Delivering optimal business performance and outcomes through integrated technology services to senior care organizations and PACE MOORESTOWN, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ [...]
Misonix to Participate in Three Upcoming Investor Conferences
08/11/2018
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
CFN Media's Exclusive Interview with Pascal Biosciences
08/11/2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Align Technology Announces $50 Million Accelerated Stock Repurchase Program
08/11/2018
SAN JOSE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) announced that it has entered into an accelerated stock repurchase agreement ("ASR") with Morgan Stanley & Co. LLC ("Morgan [...]
PSIQ Acquires Exclusive Distribution Rights to Cheech & Chong Mens Grooming Products With Hemp in the United States and Israel
08/11/2018
SUNRISE, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) through its operating subsidiary Elite Products International Inc. is pleased to announce it has acquired the EXCLUSIVE brick [...]
Hemostemix Announces Important Manufacturing Process Refinements
08/11/2018
CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that is has completed refinements to its manufacturing [...]
First Choice Healthcare Solutions Reports Third Quarter 2018 Results and Update on Strategic Initiatives
08/11/2018
MELBOURNE, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB: FCHS) ("First Choice" or the "Company") , a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
08/11/2018
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that, despite the catastrophic events [...]
Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors
08/11/2018
Basking Ridge, New Jersey, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences Appoints Cynthia Schwalm to Board of Directors BASKING RIDGE, N.J. (November 8, 2018) – Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“ [...]
Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
08/11/2018
A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass [...]
Kane Biotech Schedules Third Quarter 2018 Earnings Conference Call and Business Update
08/11/2018
Conference call to take place Thursday, November 15, 2018 at 4:30pm E.T. WINNIPEG, Manitoba, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased [...]
Cognition Therapeutics Initiates Patient Dosing in Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer's Disease
08/11/2018
Pittsburgh, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on synaptic protection and restoration in Alzheimer’s disease and other neurodegenerative [...]
Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th
08/11/2018
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
T1D Exchange Launches One-Stop Resource for the Type 1 Diabetes Community
08/11/2018
New Website Puts Patients at the Center of Accelerating Innovation and Improving Care BOSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) -- T1D Exchange today announced the launch of a new T1DExchange.org website featuring cutting- [...]
Intensity Therapeutics Highlights INT230-6 Data in Advanced Solid Tumors at Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
08/11/2018
Intratumoral injections of INT230-6 were well tolerated with no drug-related serious adverse events or dose-limiting toxicity in Phase 1/2 clinical study Preclinical research demonstrates drug dispersion benefit of [...]
Conatus Pharmaceuticals Announces Presentations and Posters at AASLD Annual Meeting
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the schedule of upcoming oral presentations and posters addressing clinical and preclinical results with the [...]
Ovid Therapeutics Reports Third Quarter 2018 Financial Results and Highlights Recent Clinical Progress
08/11/2018
OV101 in Angelman syndrome: Plan to meet with U.S. FDA in the fourth quarter of 2018 to review Phase 2 STARS results and discuss next steps for program OV935/TAK-935 in rare developmental and epileptic encephalopathies [...]
Progenics Pharmaceuticals Announces Third Quarter 2018 Financial Results And Business Update
08/11/2018
AZEDRA ® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added to the NCCN Guidelines and Four CMS-Recognized Drug Compendia Phase 3 Study of PyL TM for [...]
Kura Oncology Adds Commercial Veteran Mary Szela to Board of Directors
08/11/2018
Ms. Szela brings expertise in global brand development to Kura as company enters first registration-directed trial SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage [...]

Pages